Skip to content

NTHI NTHI Stock-Based Comp

Stock-Based Comp at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$146M+1.4%
Pfizer logo
PfizerPFE
$272M+60.0%
Merck & Co. logo
Merck & Co.MRK
$185M-5.1%
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
$1.85M+35.2%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$6.9M+5.2%
Nuvation Bio logo
Nuvation BioNUVB
$9.03M+15.0%

Other financials

Income statement

See full
Revenue$40.0K-7.0%
Operating income-$7.1M+77.9%
Net income-$8.8M+72.7%
EPS (diluted)-$0.38+78.7%

Balance sheet

See full
Cash & equivalents$138.6K-97.5%
Total debt$666.1K
Total equity-$13.2M-37.5%
Total assets$3.3M-60.6%

Cash flow

See full
Operating cash flow-$7.0M-23.7%
CapEx$125.0K
Free cash flow-$5.2M

Valuation

See full
Market cap$114.62M+51.0%
Enterprise value$115.15M+51.1%
P/S1,432.9×

Profitability

See full
Operating margin-46,870.7%
Net margin-51,613.3%
FCF margin-26,083.2%

Returns & leverage

See full
Return on equity338.1%
Debt / equity-0.1×
Current ratio0.1×-0.3×

Where this comes from

Reported directly by NTHI in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: NTHI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NTHI's stock-based comp?
NTHI (NTHI) reported stock-based comp of $2.73M in Q1 2026.
How has NTHI's stock-based comp changed year-over-year?
NTHI's stock-based comp decreased by 84.3% year-over-year, from $17.4M to $2.73M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.